Shire Regenerative Medicine Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 500

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $750M

Shire Regenerative Medicine General Information

Description

Developer of cell-based regenerative skin substitutes designed for the treatment of chronic wounds. The company's platform integrates living human skin cells within a bioengineered scaffold, manufactured under controlled conditions to support cellular proliferation, biological signaling, extracellular matrix formation, and durable tissue regeneration, with standardized composition, storage, handling characteristics, and consistent clinical performance across applications, enabling healthcare providers to evidence-based management of diabetic foot ulcers.

Contact Information

Formerly Known As
Advanced BioHealing
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 36 Church Lane
  • Westport, CT 06880
  • United States
+1 (203)
Primary Industry
Biotechnology
Corporate Office
  • 36 Church Lane
  • Westport, CT 06880
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shire Regenerative Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Jun-2011 $750M Completed Generating Revenue
4. IPO 18-May-2011 Cancelled Generating Revenue
3. Later Stage VC (Series C) 31-May-2007 Completed Generating Revenue
2. Early Stage VC (Series B) 29-Nov-2005 $8M $10.4M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Oct-2004 $2.4M $2.4M Completed Product Development
To view Shire Regenerative Medicine’s complete valuation and funding history, request access »

Shire Regenerative Medicine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 500,561 $0.001000 $4.79 $4.79 1x $4.79 4.5%
To view Shire Regenerative Medicine’s complete cap table history, request access »

Shire Regenerative Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shire Regenerative Medicine Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDIB BioScience Venture Management Venture Capital Minority
Canaan Partners Venture Capital Minority
Channel Medical Partners Venture Capital Minority
Red Abbey Venture Partners Venture Capital Minority
Safeguard Scientifics Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Shire Regenerative Medicine FAQs

  • When was Shire Regenerative Medicine founded?

    Shire Regenerative Medicine was founded in 2004.

  • Where is Shire Regenerative Medicine headquartered?

    Shire Regenerative Medicine is headquartered in Westport, CT.

  • What is the size of Shire Regenerative Medicine?

    Shire Regenerative Medicine has 500 total employees.

  • What industry is Shire Regenerative Medicine in?

    Shire Regenerative Medicine’s primary industry is Biotechnology.

  • Is Shire Regenerative Medicine a private or public company?

    Shire Regenerative Medicine is a Private company.

  • What is the current valuation of Shire Regenerative Medicine?

    The current valuation of Shire Regenerative Medicine is .

  • What is Shire Regenerative Medicine’s current revenue?

    The current revenue for Shire Regenerative Medicine is .

  • How much funding has Shire Regenerative Medicine raised over time?

    Shire Regenerative Medicine has raised $40.7M.

  • Who are Shire Regenerative Medicine’s investors?

    CDIB BioScience Venture Management, Canaan Partners, Channel Medical Partners, Red Abbey Venture Partners, and Safeguard Scientifics are 5 of 7 investors who have invested in Shire Regenerative Medicine.

  • When was Shire Regenerative Medicine acquired?

    Shire Regenerative Medicine was acquired on 28-Jun-2011.

  • Who acquired Shire Regenerative Medicine?

    Shire Regenerative Medicine was acquired by Shire (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process